Eszopiclone-Induced Psychosis

[摘要] Eszopiclone, a nonbenzodiazepine hypnotic, is approved by the United States Food and Drug Administration (FDA) for the treatment of insomnia. We report a case of new onset psychosis after initiation of treatment with eszopiclone. To the best of our knowledge, no cases of eszopiclone-induced psychosis have been reported.

[学科分类] 精神健康和精神病学